Charles Zhu Stock Analyst Profile - LifeSci Capital Research Coverage - Stocknear

Charles Zhu

Stock Analyst at LifeSci Capital

(5)
# 168
Out of 5,506 analysts
28
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:

12 Stocks

Name Action PT Current % Upside Ratings Updated
MRUS Merus
Downgrades: Market Perform
97
94.29 2.87% 7 Sep 30, 2025
CBIO Crescent Biopharma
Initiates Coverage On: Outperform
22
n/a n/a 1 Jun 18, 2025
RPTX Repare Therapeutics
Downgrades: Market Perform
n/a
n/a n/a 1 Dec 13, 2024
TNGX Tango Therapeutics
Maintains: Buy
18 8
7.76 3.09% 3 Nov 7, 2024
MGNX Macrogenics
Upgrades: Buy
12
1.78 574.16% 4 Nov 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
56
84.22 -33.51% 1 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
22
4.96 343.55% 1 Jul 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
26
15.76 64.97% 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32
27.64 15.77% 3 Mar 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
14
16.94 -17.36% 2 May 5, 2022